Jennifer C. McKelvie

A real-time assay for CpG-specific cytosine-C5 methyltransferase activity

R.J.K. Wood, Jennifer C. McKelvie, Michael Maynard-Smith et al. · Nucleic Acids Research · 2010 · 56 citations · Full text

Potent, selective small molecule inhibitors of type III phosphatidylinositol-4-kinase α- but not β-inhibit the phosphatidylinositol signaling cascade and cancer cell proliferation

Michael J. Waring, David Andrews, Paul Faulder et al. · Chemical Communications · 2013 · 34 citations

Type Iii Phosphatidylinositol-4-kinase, Cancer Cell Proliferation, Cellular Pharmacology +17

Discovery of a Thiadiazole–Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models

M. Raymond V. Finlay, Mark J. Anderton, Andrew Bailey et al. · Journal of Medicinal Chemistry · 2019 · 29 citations · Full text

Oral Bioavailability, Pharmacotherapy, Gls1 Inhibitor Bis-2- +16

Phage display screening against a set of targets to establish peptide-based sugar mimetics and molecular docking to predict binding site

Limin. Yu, Peggy Shuang Yu, Elizabeth Yee Yen Mui et al. · Bioorganic & Medicinal Chemistry · 2009 · 26 citations

Biochemistry, Natural Sciences, Medicine +10

Development of rationally designed DNA N6 adenine methyltransferase inhibitors

Gerard Hobley, Jennifer C. McKelvie, Jenny E. Harmer et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 14 citations · Full text

Natural Sciences, Oligonucleotide, Dna Replication +3